A summary of recommendations for advising patients and the public on managing heartburn and indigestion
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
Information intended for UK healthcare professionals only. These promotional videos have been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines and Guidelines Live. Promotional information regarding Norgine Pharmaceutical Limited products will be presented.
View FERACCRU® (ferric maltol) prescribing information and adverse event reporting information here
Date of preparation: May 2022
This concise consultation card was developed by Guidelines for Pharmacy in partnership with Reckitt.
Essential information and adverse reporting details are included.
RB-M-92868 May 2022
A national audit of pancreatic enzyme replacement therapy (PERT) prescribing in patients with pancreatic cancer: The RICOCHET study
This supplement has been commissioned and funded by Viatris and developed in partnership with Guidelines.
NON-2021-4065 February 2022
Improving patient outcomes: supporting pharmacists with the management of pancreatic exocrine insufficiency (PEI)
This supplement has been commissioned, funded, and reviewed by Viatris and developed in partnership with Guidelines for Pharmacy.
Information intended for UK healthcare professionals only.
NON-2021-6348 January 2022
This promotional video has been funded by Sandoz Ltd and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View prescribing information
141580 | Date of preparation: September 2021